|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00690 UNI-BIO GROUP
Nominal 
0.064 +0.001 (+1.587%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 98,849 | 48,660 | 12,042 | (15,474) | (30,749) |
| Net Cash from / (used in) Investing Activities | (76,144) | (27,029) | 42,120 | (24,647) | 51,053 |
| Net Cash from / (used in) Financing Activities | 24,513 | 2,575 | 478 | (5,406) | 13,878 |
| Increase / (Decrease) in Cash & Cash Equivalents | 47,218 | 24,206 | 54,640 | (45,527) | 34,182 |
| Cash & Cash Equivalents at beginning of period | 98,216 | 83,609 | 25,012 | 66,198 | 31,786 |
| Effect of Foreign Exchange Rate Changes | (16,198) | (9,599) | 3,957 | 4,341 | 230 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 129,236 | 98,216 | 83,609 | 25,012 | 66,198 |
| Remarks: | Real time quote last updated: 25/11/2024 10:12 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 67,382,000 |
| %Change | 71.016% |
| EPS / (LPS) | HKD 0.011 |
| NBV Per Share ($) | HKD 0.051 |